Literature DB >> 25387683

Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

Aurélie Cotillard1, Christine Poitou, Guillemette Duchâteau-Nguyen, Judith Aron-Wisnewsky, Jean-Luc Bouillot, Thomas Schindler, Karine Clément.   

Abstract

BACKGROUND: Statistical models and scores have been recently suggested to predict remission of type 2 diabetes after bypass surgery, but their relevance in routine clinical practice still needs evaluation. Our objective was to assess these methods on a French cohort and to compare them with other easy-to-use models.
METHODS: We investigated a cohort of 84 diabetic obese subjects who underwent Roux-en-Y gastric bypass surgery. Diabetes remission 1 year after surgery was defined based on the American Diabetes Association criteria. We tested six methods from the literature and four other models to predict remission of diabetes after bypass surgery using pre-operative bioclinical parameters. Predictive methods for diabetes remission were assessed using cross-validation error rates when appropriate.
RESULTS: Sixty percent of the subjects had diabetes remission. Models from the literature had high error rates in our cohort (from 22.6 to 40.5 %), while published simple scoring systems behaved much better (15.9 and 16.7 %). Using other apprehensible models learned on our cohort did not improve the prediction error (from 17.2 to 19.9 %).
CONCLUSIONS: We showed that the scoring system DiaRem is easy to use and provides the best prediction error (15.9 %) compared to other methods. We additionally propose a DiaRem score threshold of ≤6 for likely remission of a subject 1 year after surgery, which may be considered in clinical decision-making.

Entities:  

Mesh:

Year:  2015        PMID: 25387683     DOI: 10.1007/s11695-014-1511-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  15 in total

1.  Bariatric surgery versus conventional medical therapy for type 2 diabetes.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Laura Leccesi; Giuseppe Nanni; Alfons Pomp; Marco Castagneto; Giovanni Ghirlanda; Francesco Rubino
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

2.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

3.  Statistical models to predict type 2 diabetes remission after bariatric surgery.

Authors:  Ana M Ramos-Levi; Pilar Matia; Lucio Cabrerizo; Ana Barabash; Andres Sanchez-Pernaute; Alfonso L Calle-Pascual; Antonio J Torres; Miguel A Rubio
Journal:  J Diabetes       Date:  2014-02-26       Impact factor: 4.006

Review 4.  Obesity, bariatric surgery and type 2 diabetes--a systematic review.

Authors:  Cynthia V Ferchak; Luigi F Meneghini
Journal:  Diabetes Metab Res Rev       Date:  2004 Nov-Dec       Impact factor: 4.876

5.  How do we define cure of diabetes?

Authors:  John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

6.  Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study.

Authors:  Christopher D Still; G Craig Wood; Peter Benotti; Anthony T Petrick; Jon Gabrielsen; William E Strodel; Anna Ibele; Jamie Seiler; Brian A Irving; Melisa P Celaya; Robin Blackstone; Glenn S Gerhard; George Argyropoulos
Journal:  Lancet Diabetes Endocrinol       Date:  2014-01       Impact factor: 32.069

7.  Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score.

Authors:  Wei-Jei Lee; Kyung Yul Hur; Muffazal Lakadawala; Kazunori Kasama; Simon K H Wong; Shu-Chun Chen; Yi-Chih Lee; Kong-Han Ser
Journal:  Surg Obes Relat Dis       Date:  2012-08-06       Impact factor: 4.734

Review 8.  Preoperatively determinable factors predictive of diabetes mellitus remission following Roux-en-Y gastric bypass: a review of the literature.

Authors:  S T Adams; M Salhab; Z I Hussain; G V Miller; S H Leveson
Journal:  Acta Diabetol       Date:  2013-03-07       Impact factor: 4.280

9.  Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.

Authors:  W J Pories; M S Swanson; K G MacDonald; S B Long; P G Morris; B M Brown; H A Barakat; R A deRamon; G Israel; J M Dolezal
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

10.  Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders.

Authors:  D J Pournaras; E T Aasheim; T T Søvik; R Andrews; D Mahon; R Welbourn; T Olbers; C W le Roux
Journal:  Br J Surg       Date:  2011-10-21       Impact factor: 6.939

View more
  12 in total

1.  Performance of the DiaRem Score for Predicting Diabetes Remission in Two Health Systems Following Bariatric Surgery Procedures in Hispanic and non-Hispanic White Patients.

Authors:  G Craig Wood; Daniel Horwitz; Christopher D Still; Tooraj Mirshahi; Peter Benotti; Manish Parikh; Annemarie G Hirsch
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

Review 2.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

3.  The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass.

Authors:  Judith Aron-Wisnewsky; Nataliya Sokolovska; Yuejun Liu; Doron S Comaneshter; Shlomo Vinker; Tal Pecht; Christine Poitou; Jean-Michel Oppert; Jean-Luc Bouillot; Laurent Genser; Dror Dicker; Jean-Daniel Zucker; Assaf Rudich; Karine Clément
Journal:  Diabetologia       Date:  2017-07-21       Impact factor: 10.122

4.  Is Laparoscopic Roux-en-Y Gastric Bypass Still the Gold Standard Procedure for Indians? Mid- to Long-Term Outcomes from a Tertiary Care Center.

Authors:  Shivanshu Misra; B Deepa Nandhini; S Christinajoice; S Saravana Kumar; S Prabhakaran; C Palanivelu; P Praveen Raj
Journal:  Obes Surg       Date:  2020-07-29       Impact factor: 4.129

5.  Type 2 diabetes remission following gastric bypass: does diarem stand the test of time?

Authors:  J Hunter Mehaffey; Mathew G Mullen; Rachel L Mehaffey; Florence E Turrentine; Steven K Malin; Jennifer L Kirby; Bruce Schirmer; Peter T Hallowell
Journal:  Surg Endosc       Date:  2016-05-13       Impact factor: 4.584

6.  Association of DiaRem Score With Cure of Type 2 Diabetes Following Bariatric Surgery.

Authors:  G Craig Wood; Tooraj Mirshahi; Christopher D Still; Annemarie G Hirsch
Journal:  JAMA Surg       Date:  2016-08-01       Impact factor: 14.766

7.  DiaRem2: Incorporating duration of diabetes to improve prediction of diabetes remission after metabolic surgery.

Authors:  Christopher D Still; Peter Benotti; Tooraj Mirshahi; Adam Cook; G Craig Wood
Journal:  Surg Obes Relat Dis       Date:  2018-12-22       Impact factor: 4.734

8.  Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy.

Authors:  Shih-Chiang Shen; Weu Wang; Ka-Wai Tam; Hsin-An Chen; Yen-Kuang Lin; Shih-Yun Wang; Ming-Te Huang; Yen-Hao Su
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

Review 9.  The importance of prediction model validation and assessment in obesity and nutrition research.

Authors:  A E Ivanescu; P Li; B George; A W Brown; S W Keith; D Raju; D B Allison
Journal:  Int J Obes (Lond)       Date:  2015-10-09       Impact factor: 5.095

10.  Ranking factors involved in diabetes remission after bariatric surgery using machine-learning integrating clinical and genomic biomarkers.

Authors:  Helle Krogh Pedersen; Valborg Gudmundsdottir; Mette Krogh Pedersen; Caroline Brorsson; Søren Brunak; Ramneek Gupta
Journal:  NPJ Genom Med       Date:  2016-10-26       Impact factor: 8.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.